Business Description
Stella Pharma Corporation is a Japanese pharmaceutical company founded in 2007 and based in Osaka, focused on developing treatments for serious cancers. Its main product, SPM-011, is designed for use in boron neutron capture therapy, a targeted approach to fighting tumors. The drug is being developed to treat conditions including head and neck cancer, brain tumors, and several other difficult-to-treat cancers.
